HOWL

Werewolf Therapeutics, Inc.CIK 1785530 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for HOWL PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for HOWL

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
EVNIN LUKE	Director, 10% Owner	102	$2.41M	$3.26M	2026-07-07
RA CAPITAL MANAGEMENT, L.P.	Director, 10% Owner	15	$0	$710.4K	2026-06-17
Kolchinsky Peter	Director, 10% Owner	8	$0	$253.6K	2026-06-11
MPM Oncology Impact Management LP	Other	11	$3.92M	$479.1K	2025-12-04
MPM BioVentures 2014 (B), L.P.	Other	3	$0	$183.3K	2025-12-04
UBS Oncology Impact Fund L.P.	10% Owner	10	$0	$824.5K	2025-12-01
MPM Asset Management Investors BV2014 LLC	10% Owner	10	$0	$530.6K	2025-12-01
MPM Oncology Innovations Fund GP LLC	10% Owner	9	$0	$528.1K	2025-11-25
MPM BioVentures 2014 GP LLC	10% Owner	3	$0	$179.6K	2025-11-25
MPM BioVentures 2014 LLC	10% Owner	17	$2.01M	$1.09M	2025-11-20
MPM BioVentures 2014, L.P.	10% Owner	4	$0	$241.3K	2025-11-12
MPM ONCOLOGY INNOVATIONS FUND LP	10% Owner	3	$0	$391.6K	2025-11-03
Atkins Michael B.	Director	3	$0	$0	2025-06-12
Singhal Anil K.	Director	3	$0	$0	2025-06-12
Chatterjee Meeta	Director	5	$0	$0	2025-06-12
Lazarus Alon	Director, 10% Owner	11	$9.68M	$0	2025-06-12
Morrison Briggs	Director	5	$0	$0	2025-06-12
Sherman Michael A.	Director	5	$0	$0	2025-06-12
RA Capital Nexus Fund II, L.P.	Director, 10% Owner	3	$487.2K	$0	2025-05-14
Bloom Steven H.	Chief Business Officer	1	$0	$0	2025-05-01
MPM ASSET MANAGEMENT LLC	10% Owner	4	$0	$4.6K	2025-03-27
Karunatilake Chulani	Chief Technology Officer	7	$0	$0	2025-01-02
Lubman Ellen	Chief Business Officer	7	$0	$0	2025-01-02
Isaacs Randi	Chief Medical Officer	8	$0	$0	2025-01-02
Trost Timothy W.	Chief Financial Officer	7	$0	$0	2025-01-02
HICKLIN DANIEL J	See Remarks	7	$0	$0	2025-01-02
DiRocco Derek	Director	4	$0	$0	2024-05-24
Seidel-Dugan Cynthia	Chief Scientific Officer	9	$0	$0	2024-01-02
Shah Rajeev M.	Director, 10% Owner	7	$31.54M	$0	2023-01-06
Leonard Reid	Chief Operating Officer	8	$0	$40.2K	2023-01-03
RA Capital Healthcare Fund LP	Director, 10% Owner	3	$4.13M	$0	2021-06-16
Taiho Ventures LLC	10% Owner	5	$5.00M	$0	2021-05-04
Asanuma Sakae	Director, 10% Owner	6	$8.49M	$0	2021-05-04
UPMC	10% Owner	4	$0	$0	2021-05-04
Longwood Fund III, L.P.	10% Owner	5	$4.00M	$0	2021-05-04
Sphera Global Healthcare Management LP	10% Owner	3	$7.60M	$0	2021-05-04
Flynn James E	10% Owner	3	$12.80M	$0	2021-05-04
Arkin Moshe	10% Owner	5	$6.40M	$0	2021-05-04
HBM Healthcare Investments (Cayman) Ltd.	10% Owner	2	$0	$0	2021-05-04

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
EVNIN LUKE	Director	S Sale	2026-07-07	2026-07-08	107,429	$0.31	$33.3K	0	SEC↗
EVNIN LUKE	Director	S Sale	2026-07-06	2026-07-08	35,770	$0.32	$11.4K	107,429	SEC↗
EVNIN LUKE	Director	S Sale	2026-06-29	2026-06-29	157,084	$0.30	$47.1K	143,199	SEC↗
RA CAPITAL MANAGEMENT, L.P.	10% Owner	S Sale	2026-06-17	2026-06-22	27,695	$0.35	$9.7K	303,719	SEC↗
RA CAPITAL MANAGEMENT, L.P.	10% Owner	S Sale	2026-06-17	2026-06-22	389,216	$0.35	$136.2K	4,268,448	SEC↗
RA CAPITAL MANAGEMENT, L.P.	10% Owner	S Sale	2026-06-16	2026-06-16	9,939	$0.37	$3.7K	331,414	SEC↗
RA CAPITAL MANAGEMENT, L.P.	10% Owner	S Sale	2026-06-16	2026-06-16	139,686	$0.37	$51.7K	4,657,664	SEC↗
RA CAPITAL MANAGEMENT, L.P.	10% Owner	S Sale	2026-06-15	2026-06-16	8,554	$0.39	$3.3K	341,353	SEC↗
RA CAPITAL MANAGEMENT, L.P.	10% Owner	S Sale	2026-06-15	2026-06-16	120,216	$0.39	$46.9K	4,797,350	SEC↗
RA CAPITAL MANAGEMENT, L.P.	10% Owner	S Sale	2026-06-12	2026-06-16	11,322	$0.40	$4.5K	349,907	SEC↗
RA CAPITAL MANAGEMENT, L.P.	10% Owner	S Sale	2026-06-12	2026-06-16	159,119	$0.40	$63.6K	4,917,566	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2026-06-11	2026-06-11	245,066	$0.38	$93.1K	5,076,685	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2026-06-11	2026-06-11	17,437	$0.38	$6.6K	361,229	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2026-06-10	2026-06-11	3,051	$0.37	$1.1K	378,666	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2026-06-10	2026-06-11	42,872	$0.37	$15.9K	5,321,751	SEC↗
EVNIN LUKE	Director	S Sale	2026-06-09	2026-06-10	76,928	$0.37	$28.5K	300,283	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2026-06-09	2026-06-11	24,565	$0.37	$9.1K	381,717	SEC↗
Kolchinsky Peter	10% Owner	S Sale	2026-06-09	2026-06-11	345,235	$0.37	$127.7K	5,364,623	SEC↗
EVNIN LUKE	Director	S Sale	2026-06-08	2026-06-08	60,547	$0.40	$24.2K	377,211	SEC↗
EVNIN LUKE	Director	S Sale	2026-06-05	2026-06-08	24,946	$0.40	$10.0K	437,758	SEC↗
EVNIN LUKE	Director	S Sale	2026-06-04	2026-06-08	20,072	$0.44	$8.8K	462,704	SEC↗
EVNIN LUKE	Director	S Sale	2026-06-03	2026-06-03	29,749	$0.42	$12.5K	482,776	SEC↗
EVNIN LUKE	Director	S Sale	2026-06-02	2026-06-03	29,595	$0.45	$13.3K	512,525	SEC↗
EVNIN LUKE	Director	S Sale	2026-06-01	2026-06-03	80,459	$0.47	$37.8K	542,120	SEC↗
EVNIN LUKE	Director	S Sale	2026-05-29	2026-05-29	32,556	$0.45	$14.7K	622,579	SEC↗
EVNIN LUKE	Director	S Sale	2026-05-28	2026-05-29	27,698	$0.46	$12.7K	655,135	SEC↗
EVNIN LUKE	Director	S Sale	2026-05-27	2026-05-29	80,852	$0.48	$38.8K	682,833	SEC↗
EVNIN LUKE	Director	S Sale	2026-05-26	2026-05-26	67,950	$0.47	$31.9K	763,685	SEC↗
EVNIN LUKE	Director	S Sale	2026-05-22	2026-05-26	87,425	$0.45	$39.3K	831,635	SEC↗
EVNIN LUKE	Director	S Sale	2026-05-21	2026-05-26	36,387	$0.42	$15.3K	919,060	SEC↗
EVNIN LUKE	Director	S Sale	2026-05-20	2026-05-20	85,895	$0.43	$36.9K	955,447	SEC↗
EVNIN LUKE	Director	S Sale	2026-05-19	2026-05-20	62,970	$0.45	$28.3K	1,041,342	SEC↗
EVNIN LUKE	Director	S Sale	2026-05-18	2026-05-20	22,184	$0.50	$11.1K	1,104,312	SEC↗
EVNIN LUKE	Director	S Sale	2026-05-13	2026-05-13	44,679	$0.54	$24.1K	1,126,496	SEC↗
RA CAPITAL MANAGEMENT, L.P.	10% Owner	S Sale	2026-05-12	2026-05-12	94,432	$0.64	$60.4K	5,709,858	SEC↗
RA CAPITAL MANAGEMENT, L.P.	10% Owner	S Sale	2026-05-12	2026-05-12	6,719	$0.64	$4.3K	406,282	SEC↗
EVNIN LUKE	Director	S Sale	2026-05-12	2026-05-12	67,885	$0.64	$43.4K	1,171,175	SEC↗
RA CAPITAL MANAGEMENT, L.P.	10% Owner	S Sale	2026-05-11	2026-05-12	81,678	$0.67	$54.7K	5,804,290	SEC↗
RA CAPITAL MANAGEMENT, L.P.	10% Owner	S Sale	2026-05-11	2026-05-12	5,812	$0.67	$3.9K	413,001	SEC↗
EVNIN LUKE	Director	S Sale	2026-05-11	2026-05-12	33,948	$0.67	$22.7K	1,239,060	SEC↗
RA CAPITAL MANAGEMENT, L.P.	10% Owner	S Sale	2026-05-08	2026-05-12	25,012	$0.71	$17.8K	418,813	SEC↗
RA CAPITAL MANAGEMENT, L.P.	10% Owner	S Sale	2026-05-08	2026-05-12	351,514	$0.71	$249.6K	5,885,968	SEC↗
EVNIN LUKE	Director	S Sale	2026-05-08	2026-05-12	305,741	$0.70	$214.0K	1,273,008	SEC↗
EVNIN LUKE	Director	S Sale	2026-05-07	2026-05-07	79,086	$0.63	$49.8K	1,578,749	SEC↗
EVNIN LUKE	Director	S Sale	2026-05-06	2026-05-07	14,635	$0.66	$9.7K	1,657,835	SEC↗
EVNIN LUKE	Director	S Sale	2026-05-05	2026-05-07	6,860	$0.69	$4.7K	1,672,470	SEC↗
EVNIN LUKE	Director	S Sale	2026-05-04	2026-05-04	47,963	$0.72	$34.5K	1,679,330	SEC↗
EVNIN LUKE	Director	S Sale	2026-05-01	2026-05-04	58,394	$0.73	$42.6K	1,727,293	SEC↗
EVNIN LUKE	Director	S Sale	2026-04-30	2026-05-04	168,262	$0.72	$121.1K	1,785,687	SEC↗
EVNIN LUKE	Director	S Sale	2026-04-29	2026-04-29	56,559	$0.69	$39.0K	1,953,949	SEC↗
EVNIN LUKE	Director	S Sale	2026-04-28	2026-04-29	95,412	$0.73	$69.7K	2,010,508	SEC↗
EVNIN LUKE	Director	S Sale	2026-04-27	2026-04-29	53,940	$0.85	$45.8K	2,105,920	SEC↗
EVNIN LUKE	Director	S Sale	2026-01-16	2026-01-20	38,782	$0.54	$20.9K	2,159,860	SEC↗
EVNIN LUKE	Director	S Sale	2026-01-15	2026-01-15	37,413	$0.55	$20.6K	2,198,642	SEC↗
EVNIN LUKE	Director	S Sale	2026-01-14	2026-01-15	30,616	$0.57	$17.5K	2,236,055	SEC↗
EVNIN LUKE	Director	S Sale	2026-01-13	2026-01-15	43,198	$0.55	$23.8K	2,266,671	SEC↗
EVNIN LUKE	Director	S Sale	2026-01-12	2026-01-12	58,980	$0.57	$33.6K	2,309,869	SEC↗
EVNIN LUKE	Director	S Sale	2026-01-09	2026-01-12	24,678	$0.61	$15.1K	2,368,849	SEC↗
EVNIN LUKE	Director	S Sale	2026-01-08	2026-01-12	7,716	$0.63	$4.9K	2,393,527	SEC↗
EVNIN LUKE	Director	S Sale	2026-01-07	2026-01-07	11,915	$0.64	$7.6K	2,401,243	SEC↗
EVNIN LUKE	Director	S Sale	2026-01-06	2026-01-07	40,761	$0.65	$26.5K	2,413,158	SEC↗
EVNIN LUKE	Director	S Sale	2026-01-05	2026-01-07	18,378	$0.64	$11.8K	2,453,919	SEC↗
EVNIN LUKE	Director	S Sale	2026-01-02	2026-01-02	18,568	$0.63	$11.7K	2,472,297	SEC↗
EVNIN LUKE	Director	S Sale	2025-12-31	2026-01-02	24,962	$0.62	$15.5K	2,490,865	SEC↗
EVNIN LUKE	Director	S Sale	2025-12-30	2026-01-02	34,847	$0.61	$21.3K	2,515,827	SEC↗
EVNIN LUKE	Director	S Sale	2025-12-29	2025-12-29	108,606	$0.61	$66.2K	2,550,674	SEC↗
EVNIN LUKE	Director	S Sale	2025-12-26	2025-12-29	35,632	$0.63	$22.4K	2,659,280	SEC↗
EVNIN LUKE	Director	S Sale	2025-12-24	2025-12-29	16,310	$0.65	$10.6K	2,694,912	SEC↗
EVNIN LUKE	Director	S Sale	2025-12-23	2025-12-29	71,428	$0.63	$45.0K	2,711,222	SEC↗
EVNIN LUKE	Director	S Sale	2025-12-22	2025-12-29	59,307	$0.69	$40.9K	2,782,650	SEC↗
EVNIN LUKE	Director	S Sale	2025-12-17	2025-12-17	9,983	$1.14	$11.4K	2,841,957	SEC↗
EVNIN LUKE	Director	S Sale	2025-12-16	2025-12-17	14,548	$1.05	$15.3K	2,851,940	SEC↗
EVNIN LUKE	Director	S Sale	2025-12-15	2025-12-17	23,640	$1.07	$25.3K	2,866,488	SEC↗
EVNIN LUKE	Director	S Sale	2025-12-12	2025-12-12	17,858	$1.08	$19.3K	2,890,128	SEC↗
EVNIN LUKE	Director	S Sale	2025-12-11	2025-12-12	28,009	$1.07	$30.0K	2,907,986	SEC↗
EVNIN LUKE	Director	S Sale	2025-12-10	2025-12-12	37,104	$1.06	$39.3K	2,935,995	SEC↗
EVNIN LUKE	Director	S Sale	2025-12-09	2025-12-09	44,570	$1.01	$45.0K	2,973,099	SEC↗
EVNIN LUKE	Director	S Sale	2025-12-08	2025-12-09	34,041	$0.99	$33.7K	3,017,669	SEC↗
EVNIN LUKE	Director	S Sale	2025-12-05	2025-12-09	16,568	$0.97	$16.1K	3,051,710	SEC↗
MPM BioImpact LLC	Other	S Sale	2025-12-04	2025-12-04	83,230	$0.97	$80.7K	4,784,111	SEC↗
MPM BioVentures 2014 (B), L.P.	Other	S Sale	2025-12-04	2025-12-04	83,230	$0.97	$80.7K	4,784,111	SEC↗
EVNIN LUKE	Director	S Sale	2025-12-04	2025-12-04	53,416	$0.97	$51.8K	3,068,278	SEC↗
MPM BioImpact LLC	Other	S Sale	2025-12-03	2025-12-04	57,225	$0.87	$49.8K	4,867,341	SEC↗
MPM BioVentures 2014 (B), L.P.	Other	S Sale	2025-12-03	2025-12-04	57,225	$0.87	$49.8K	4,867,341	SEC↗
EVNIN LUKE	Director	S Sale	2025-12-03	2025-12-04	36,726	$0.87	$32.0K	3,121,694	SEC↗
MPM BioImpact LLC	Other	S Sale	2025-12-02	2025-12-04	59,277	$0.89	$52.8K	4,924,566	SEC↗
MPM BioVentures 2014 (B), L.P.	Other	S Sale	2025-12-02	2025-12-04	59,277	$0.89	$52.8K	4,924,566	SEC↗
EVNIN LUKE	Director	S Sale	2025-12-02	2025-12-04	38,043	$0.89	$33.9K	3,158,420	SEC↗
UBS Oncology Impact Fund L.P.	10% Owner	S Sale	2025-12-01	2025-12-01	60,917	$0.94	$57.3K	4,983,843	SEC↗
MPM Asset Management Investors	10% Owner	S Sale	2025-12-01	2025-12-01	60,917	$0.94	$57.3K	4,983,843	SEC↗
EVNIN LUKE	Director	S Sale	2025-12-01	2025-12-01	39,096	$0.94	$36.8K	3,196,463	SEC↗
UBS Oncology Impact Fund L.P.	10% Owner	S Sale	2025-11-28	2025-12-01	20,277	$0.99	$20.1K	5,044,760	SEC↗
MPM Asset Management Investors	10% Owner	S Sale	2025-11-28	2025-12-01	20,277	$0.99	$20.1K	5,044,760	SEC↗
EVNIN LUKE	Director	S Sale	2025-11-28	2025-12-01	13,014	$0.99	$12.9K	3,235,559	SEC↗
UBS Oncology Impact Fund L.P.	10% Owner	S Sale	2025-11-26	2025-12-01	60,733	$0.98	$59.5K	5,065,037	SEC↗
MPM Asset Management Investors	10% Owner	S Sale	2025-11-26	2025-12-01	60,733	$0.98	$59.5K	5,065,037	SEC↗
EVNIN LUKE	Director	S Sale	2025-11-26	2025-12-01	38,978	$0.98	$38.2K	3,248,573	SEC↗
MPM Oncology Innovations Fund	10% Owner	S Sale	2025-11-25	2025-11-25	42,533	$0.92	$39.1K	5,125,770	SEC↗
MPM BioVentures 2014 GP LLC	10% Owner	S Sale	2025-11-25	2025-11-25	42,533	$0.92	$39.1K	5,125,770	SEC↗
EVNIN LUKE	Director	S Sale	2025-11-25	2025-11-25	27,297	$0.92	$25.1K	3,287,551	SEC↗
MPM Oncology Innovations Fund	10% Owner	S Sale	2025-11-24	2025-11-25	88,802	$0.98	$87.0K	5,168,303	SEC↗
MPM BioVentures 2014 GP LLC	10% Owner	S Sale	2025-11-24	2025-11-25	88,802	$0.98	$87.0K	5,168,303	SEC↗
EVNIN LUKE	Director	S Sale	2025-11-24	2025-11-25	56,992	$0.98	$55.9K	3,314,848	SEC↗
MPM Oncology Innovations Fund	10% Owner	S Sale	2025-11-21	2025-11-25	64,331	$0.83	$53.4K	5,257,105	SEC↗
MPM BioVentures 2014 GP LLC	10% Owner	S Sale	2025-11-21	2025-11-25	64,331	$0.83	$53.4K	5,257,105	SEC↗
EVNIN LUKE	Director	S Sale	2025-11-21	2025-11-25	41,287	$0.83	$34.3K	3,371,840	SEC↗
MPM Oncology Innovations Fund	10% Owner	S Sale	2025-11-20	2025-11-20	41,152	$0.89	$36.6K	5,321,436	SEC↗
MPM BioVentures 2014 LLC	10% Owner	S Sale	2025-11-20	2025-11-20	41,152	$0.89	$36.6K	5,321,436	SEC↗
EVNIN LUKE	Director	S Sale	2025-11-20	2025-11-20	26,411	$0.89	$23.5K	3,413,127	SEC↗
MPM Oncology Innovations Fund	10% Owner	S Sale	2025-11-19	2025-11-20	66,324	$0.94	$62.3K	5,362,588	SEC↗
MPM BioVentures 2014 LLC	10% Owner	S Sale	2025-11-19	2025-11-20	66,324	$0.94	$62.3K	5,362,588	SEC↗
EVNIN LUKE	Director	S Sale	2025-11-19	2025-11-20	42,566	$0.94	$40.0K	3,439,538	SEC↗
MPM Oncology Innovations Fund	10% Owner	S Sale	2025-11-18	2025-11-20	52,627	$0.93	$48.9K	5,428,912	SEC↗
MPM BioVentures 2014 LLC	10% Owner	S Sale	2025-11-18	2025-11-20	52,627	$0.93	$48.9K	5,428,912	SEC↗
EVNIN LUKE	Director	S Sale	2025-11-18	2025-11-20	33,776	$0.93	$31.4K	3,482,104	SEC↗
MPM Oncology Innovations Fund	10% Owner	S Sale	2025-11-17	2025-11-17	57,061	$0.95	$54.2K	5,481,539	SEC↗
MPM BioVentures 2014 LLC	10% Owner	S Sale	2025-11-17	2025-11-17	57,061	$0.95	$54.2K	5,481,539	SEC↗
EVNIN LUKE	Director	S Sale	2025-11-17	2025-11-17	36,621	$0.95	$34.8K	3,515,880	SEC↗
MPM Oncology Innovations Fund	10% Owner	S Sale	2025-11-14	2025-11-17	61,640	$0.93	$57.3K	5,538,600	SEC↗
MPM BioVentures 2014 LLC	10% Owner	S Sale	2025-11-14	2025-11-17	61,640	$0.93	$57.3K	5,538,600	SEC↗
EVNIN LUKE	Director	S Sale	2025-11-14	2025-11-17	39,560	$0.93	$36.8K	3,552,501	SEC↗
MPM Oncology Innovations Fund	10% Owner	S Sale	2025-11-13	2025-11-17	90,951	$0.98	$89.1K	5,600,240	SEC↗
MPM BioVentures 2014 LLC	10% Owner	S Sale	2025-11-13	2025-11-17	90,951	$0.98	$89.1K	5,600,240	SEC↗
EVNIN LUKE	Director	S Sale	2025-11-13	2025-11-17	58,372	$0.98	$57.2K	3,592,061	SEC↗
UBS Oncology Impact Fund L.P.	10% Owner	S Sale	2025-11-12	2025-11-12	40,669	$1.09	$44.3K	5,691,191	SEC↗
MPM BioVentures 2014, L.P.	10% Owner	S Sale	2025-11-12	2025-11-12	40,669	$1.09	$44.3K	5,691,191	SEC↗
EVNIN LUKE	Director	S Sale	2025-11-12	2025-11-12	26,101	$1.09	$28.5K	3,650,433	SEC↗
UBS Oncology Impact Fund L.P.	10% Owner	S Sale	2025-11-11	2025-11-12	55,810	$1.14	$63.6K	5,731,860	SEC↗
MPM BioVentures 2014, L.P.	10% Owner	S Sale	2025-11-11	2025-11-12	55,810	$1.14	$63.6K	5,731,860	SEC↗
EVNIN LUKE	Director	S Sale	2025-11-11	2025-11-12	35,818	$1.14	$40.8K	3,676,534	SEC↗
UBS Oncology Impact Fund L.P.	10% Owner	S Sale	2025-11-10	2025-11-12	48,570	$1.18	$57.3K	5,787,670	SEC↗
MPM BioVentures 2014, L.P.	10% Owner	S Sale	2025-11-10	2025-11-12	48,570	$1.18	$57.3K	5,787,670	SEC↗
EVNIN LUKE	Director	S Sale	2025-11-10	2025-11-12	31,172	$1.18	$36.8K	3,712,352	SEC↗
UBS Oncology Impact Fund L.P.	10% Owner	S Sale	2025-11-07	2025-11-12	68,480	$1.11	$76.0K	5,836,240	SEC↗
MPM BioVentures 2014, L.P.	10% Owner	S Sale	2025-11-07	2025-11-12	68,480	$1.11	$76.0K	5,836,240	SEC↗
EVNIN LUKE	Director	S Sale	2025-11-07	2025-11-12	43,950	$1.11	$48.8K	3,743,524	SEC↗
MPM BioImpact LLC	10% Owner	S Sale	2025-11-06	2025-11-06	54,452	$1.21	$65.9K	5,904,720	SEC↗
MPM BioVentures 2014 LLC	10% Owner	S Sale	2025-11-06	2025-11-06	54,452	$1.21	$65.9K	5,904,720	SEC↗
EVNIN LUKE	Director	S Sale	2025-11-06	2025-11-06	34,947	$1.21	$42.3K	3,787,474	SEC↗
MPM BioImpact LLC	10% Owner	S Sale	2025-11-05	2025-11-06	47,950	$1.22	$58.5K	5,959,172	SEC↗
MPM BioVentures 2014 LLC	10% Owner	S Sale	2025-11-05	2025-11-06	47,950	$1.22	$58.5K	5,959,172	SEC↗
EVNIN LUKE	Director	S Sale	2025-11-05	2025-11-06	30,774	$1.22	$37.5K	3,822,421	SEC↗
MPM BioImpact LLC	10% Owner	S Sale	2025-11-04	2025-11-06	140,488	$1.22	$171.4K	6,007,122	SEC↗
MPM BioVentures 2014 LLC	10% Owner	S Sale	2025-11-04	2025-11-06	140,488	$1.22	$171.4K	6,007,122	SEC↗
EVNIN LUKE	Director	S Sale	2025-11-04	2025-11-06	90,164	$1.22	$110.0K	3,853,195	SEC↗
MPM ONCOLOGY INNOVATIONS FUND	10% Owner	S Sale	2025-11-03	2025-11-03	94,063	$1.29	$121.3K	6,147,610	SEC↗
MPM Asset Management Investors	10% Owner	S Sale	2025-11-03	2025-11-03	94,063	$1.29	$121.3K	6,147,610	SEC↗
EVNIN LUKE	Director	S Sale	2025-11-03	2025-11-03	60,369	$1.29	$77.9K	3,943,359	SEC↗
MPM ONCOLOGY INNOVATIONS FUND	10% Owner	S Sale	2025-10-31	2025-11-03	114,044	$1.28	$146.0K	6,241,673	SEC↗
MPM Asset Management Investors	10% Owner	S Sale	2025-10-31	2025-11-03	114,044	$1.28	$146.0K	6,241,673	SEC↗
EVNIN LUKE	Director	S Sale	2025-10-31	2025-11-03	73,192	$1.28	$93.7K	4,003,728	SEC↗
MPM ONCOLOGY INNOVATIONS FUND	10% Owner	S Sale	2025-10-30	2025-11-03	86,936	$1.43	$124.3K	6,355,717	SEC↗
MPM Asset Management Investors	10% Owner	S Sale	2025-10-30	2025-11-03	86,936	$1.43	$124.3K	6,355,717	SEC↗
EVNIN LUKE	Director	S Sale	2025-10-30	2025-11-03	55,795	$1.43	$79.8K	4,076,920	SEC↗
UBS Oncology Impact Fund L.P.	10% Owner	S Sale	2025-10-29	2025-10-29	134,240	$1.55	$208.1K	6,442,653	SEC↗
MPM BioVentures 2014 LLC	10% Owner	S Sale	2025-10-29	2025-10-29	134,240	$1.55	$208.1K	6,442,653	SEC↗
EVNIN LUKE	Director	S Sale	2025-10-29	2025-10-29	86,154	$1.55	$133.5K	4,132,715	SEC↗
UBS Oncology Impact Fund L.P.	10% Owner	S Sale	2025-10-28	2025-10-29	69,068	$1.64	$113.3K	6,576,893	SEC↗
MPM BioVentures 2014 LLC	10% Owner	S Sale	2025-10-28	2025-10-29	69,068	$1.64	$113.3K	6,576,893	SEC↗
EVNIN LUKE	Director	S Sale	2025-10-28	2025-10-29	44,327	$1.64	$72.7K	4,218,869	SEC↗
UBS Oncology Impact Fund L.P.	10% Owner	S Sale	2025-10-27	2025-10-29	72,709	$1.72	$125.1K	6,645,961	SEC↗
MPM BioVentures 2014 LLC	10% Owner	S Sale	2025-10-27	2025-10-29	72,709	$1.72	$125.1K	6,645,961	SEC↗
EVNIN LUKE	Director	S Sale	2025-10-27	2025-10-29	46,664	$1.72	$80.3K	4,263,196	SEC↗
Atkins Michael B.	Director	A Award deriv	2025-06-12	2025-06-13	27,000	—	$0	27,000	SEC↗
Sherman Michael A.	Director	A Award deriv	2025-06-12	2025-06-13	27,000	—	$0	27,000	SEC↗
Singhal Anil K.	Director	A Award deriv	2025-06-12	2025-06-13	8,358	—	$0	8,358	SEC↗
EVNIN LUKE	Director	A Award deriv	2025-06-12	2025-06-13	27,000	—	$0	27,000	SEC↗
Chatterjee Meeta	Director	A Award deriv	2025-06-12	2025-06-13	27,000	—	$0	27,000	SEC↗
Morrison Briggs	Director	A Award deriv	2025-06-12	2025-06-13	27,000	—	$0	27,000	SEC↗
Lazarus Alon	Director	A Award deriv	2025-06-12	2025-06-13	27,000	—	$0	27,000	SEC↗
Singhal Anil K.	Director	A Award deriv	2025-06-11	2025-06-13	9,000	—	$0	9,000	SEC↗
RA Capital Nexus Fund II, L.P.	Director, 10% Owner	P Buy	2025-05-14	2025-05-14	162,539	$0.98	$159.3K	6,237,482	SEC↗
RA Capital Nexus Fund II, L.P.	Director, 10% Owner	P Buy	2025-05-13	2025-05-14	52,974	$0.98	$51.9K	6,074,943	SEC↗
RA Capital Nexus Fund II, L.P.	Director, 10% Owner	P Buy	2025-05-12	2025-05-14	320,913	$0.86	$276.0K	6,021,969	SEC↗
Bloom Steven H.	Chief Business Officer	A Award deriv	2025-05-01	2025-05-02	201,720	—	$0	201,720	SEC↗
MPM ASSET MANAGEMENT LLC	10% Owner	X Exercise deriv	2025-03-27	2025-04-30	8,031	—	$0	0	SEC↗
MPM ASSET MANAGEMENT LLC	10% Owner	X Exercise deriv	2025-03-27	2025-04-30	42,842	—	$0	0	SEC↗
EVNIN LUKE	Director, 10% Owner	X Exercise deriv	2025-03-27	2025-04-30	4,015	—	$0	0	SEC↗
EVNIN LUKE	Director, 10% Owner	X Exercise deriv	2025-03-27	2025-04-30	24,098	—	$0	0	SEC↗
MPM Asset Management Investors	10% Owner	X Exercise deriv	2025-03-27	2025-04-30	18,743	—	$0	0	SEC↗
MPM Asset Management Investors	10% Owner	X Exercise deriv	2025-03-27	2025-04-30	4,015	—	$0	0	SEC↗
MPM ASSET MANAGEMENT LLC	10% Owner	X Exercise	2025-03-27	2025-04-30	50,873	$0.09	$4.6K	6,723,056	SEC↗
MPM ASSET MANAGEMENT LLC	10% Owner	S Sale	2025-03-27	2025-04-30	4,386	$1.05	$4.6K	6,718,670	SEC↗
EVNIN LUKE	Director, 10% Owner	X Exercise	2025-03-27	2025-04-30	28,113	$0.09	$2.5K	4,312,285	SEC↗
EVNIN LUKE	Director, 10% Owner	S Sale	2025-03-27	2025-04-30	2,425	$1.05	$2.5K	4,309,860	SEC↗
MPM Asset Management Investors	10% Owner	S Sale	2025-03-27	2025-04-30	1,963	$1.05	$2.1K	3,208,793	SEC↗
MPM Asset Management Investors	10% Owner	X Exercise	2025-03-27	2025-04-30	22,758	$0.09	$2.0K	3,210,756	SEC↗
Singhal Anil K.	Director	A Award deriv	2025-02-19	2025-02-21	45,000	—	$0	45,000	SEC↗
HICKLIN DANIEL J	See Remarks	A Award deriv	2025-01-02	2025-01-06	185,652	—	$0	185,652	SEC↗
HICKLIN DANIEL J	See Remarks	A Award deriv	2025-01-02	2025-01-06	592,690	—	$0	592,690	SEC↗
Karunatilake Chulani	Chief Technology Officer	A Award deriv	2025-01-02	2025-01-06	153,129	—	$0	153,129	SEC↗
Karunatilake Chulani	Chief Technology Officer	A Award deriv	2025-01-02	2025-01-06	150,000	—	$0	150,000	SEC↗
Isaacs Randi	Chief Medical Officer	A Award deriv	2025-01-02	2025-01-06	68,151	—	$0	68,151	SEC↗
Isaacs Randi	Chief Medical Officer	A Award deriv	2025-01-02	2025-01-06	187,500	—	$0	187,500	SEC↗
Trost Timothy W.	Chief Financial Officer	A Award deriv	2025-01-02	2025-01-06	60,358	—	$0	60,358	SEC↗
Trost Timothy W.	Chief Financial Officer	A Award deriv	2025-01-02	2025-01-06	150,000	—	$0	150,000	SEC↗
Lubman Ellen	Chief Business Officer	A Award deriv	2025-01-02	2025-01-06	131,900	—	$0	131,900	SEC↗
Lazarus Alon	Director	A Award deriv	2024-05-24	2024-05-24	17,500	—	$0	17,500	SEC↗
EVNIN LUKE	Director	A Award deriv	2024-05-24	2024-05-24	17,500	—	$0	17,500	SEC↗
Sherman Michael A.	Director	A Award deriv	2024-05-24	2024-05-24	17,500	—	$0	17,500	SEC↗
Chatterjee Meeta	Director	A Award deriv	2024-05-24	2024-05-24	17,500	—	$0	17,500	SEC↗
Atkins Michael B.	Director	A Award deriv	2024-05-24	2024-05-24	6,723	—	$0	6,723	SEC↗
Morrison Briggs	Director	A Award deriv	2024-05-24	2024-05-24	17,500	—	$0	17,500	SEC↗
DiRocco Derek	Director	A Award deriv	2024-05-24	2024-05-24	17,500	—	$0	17,500	SEC↗
RA CAPITAL MANAGEMENT, L.P.	Director, 10% Owner	A Award deriv	2024-05-24	2024-05-24	17,500	—	$0	17,500	SEC↗
Atkins Michael B.	Director	A Award deriv	2024-01-04	2024-01-04	35,000	—	$0	35,000	SEC↗
HICKLIN DANIEL J	See Remarks	A Award deriv	2024-01-02	2024-01-04	435,000	—	$0	435,000	SEC↗
Seidel-Dugan Cynthia	Chief Scientific Officer	A Award deriv	2024-01-02	2024-01-04	150,000	—	$0	150,000	SEC↗
Karunatilake Chulani	Chief Technology Officer	A Award deriv	2024-01-02	2024-01-04	150,000	—	$0	150,000	SEC↗
Isaacs Randi	Chief Medical Officer	A Award deriv	2024-01-02	2024-01-04	200,000	—	$0	200,000	SEC↗
Lubman Ellen	Chief Business Officer	A Award deriv	2024-01-02	2024-01-04	131,900	—	$0	131,900	SEC↗
Trost Timothy W.	Chief Financial Officer	A Award deriv	2024-01-02	2024-01-04	150,000	—	$0	150,000	SEC↗
Sherman Michael A.	Director	A Award deriv	2023-06-21	2023-06-23	13,200	—	$0	13,200	SEC↗
Chatterjee Meeta	Director	A Award deriv	2023-06-21	2023-06-23	13,200	—	$0	13,200	SEC↗
DiRocco Derek	Director	A Award deriv	2023-06-21	2023-06-23	13,200	—	$0	13,200	SEC↗
Lazarus Alon	Director	A Award deriv	2023-06-21	2023-06-23	13,200	—	$0	13,200	SEC↗
EVNIN LUKE	Director	A Award deriv	2023-06-21	2023-06-23	13,200	—	$0	13,200	SEC↗
Morrison Briggs	Director	A Award deriv	2023-06-21	2023-06-23	13,200	—	$0	13,200	SEC↗
Kolchinsky Peter	Director, 10% Owner	A Award deriv	2023-06-21	2023-06-23	13,200	—	$0	13,200	SEC↗
Shah Rajeev M.	Director, 10% Owner	P Buy	2023-01-06	2023-01-10	1,853,000	$2.21	$4.10M	5,701,056	SEC↗
Isaacs Randi	Chief Medical Officer	A Award deriv	2023-01-03	2023-01-09	103,300	—	$0	103,300	SEC↗
Leonard Reid	Chief Operating Officer	A Award deriv	2023-01-03	2023-01-09	93,600	—	$0	93,600	SEC↗
Trost Timothy W.	Chief Financial Officer	A Award deriv	2023-01-03	2023-01-09	102,800	—	$0	102,800	SEC↗
Karunatilake Chulani	Chief Technology Officer	A Award deriv	2023-01-03	2023-01-09	103,600	—	$0	103,600	SEC↗
Seidel-Dugan Cynthia	Chief Scientific Officer	A Award deriv	2023-01-03	2023-01-09	115,900	—	$0	115,900	SEC↗
Lubman Ellen	Chief Business Officer	A Award deriv	2023-01-03	2023-01-09	86,200	—	$0	86,200	SEC↗
HICKLIN DANIEL J	See Remarks	A Award deriv	2023-01-03	2023-01-09	295,500	—	$0	295,500	SEC↗
Chatterjee Meeta	Director	A Award deriv	2022-06-01	2022-06-03	7,733	—	$0	7,733	SEC↗
Lazarus Alon	Director	A Award deriv	2022-06-01	2022-06-03	11,600	—	$0	11,600	SEC↗
Sherman Michael A.	Director	A Award deriv	2022-06-01	2022-06-03	11,600	—	$0	11,600	SEC↗
Karunatilake Chulani	Chief Technology Officer	A Award deriv	2022-06-01	2022-06-03	136,000	—	$0	136,000	SEC↗
Morrison Briggs	Director	A Award deriv	2022-06-01	2022-06-03	11,600	—	$0	11,600	SEC↗
DiRocco Derek	Director	A Award deriv	2022-06-01	2022-06-03	11,600	—	$0	11,600	SEC↗
EVNIN LUKE	Director	A Award deriv	2022-06-01	2022-06-03	11,600	—	$0	11,600	SEC↗
Kolchinsky Peter	Director, 10% Owner	A Award deriv	2022-06-01	2022-06-03	11,600	—	$0	11,600	SEC↗
Seidel-Dugan Cynthia	Chief Scientific Officer	M Exercise deriv	2022-01-12	2022-01-14	24,199	—	$0	36,937	SEC↗
Seidel-Dugan Cynthia	Chief Scientific Officer	M Exercise deriv	2022-01-12	2022-01-14	15,532	—	$0	83,631	SEC↗
Seidel-Dugan Cynthia	Chief Scientific Officer	M Exercise	2022-01-12	2022-01-14	24,199	$1.56	$37.8K	149,356	SEC↗
Seidel-Dugan Cynthia	Chief Scientific Officer	M Exercise	2022-01-12	2022-01-14	15,532	$4.77	$74.1K	164,888	SEC↗
Seidel-Dugan Cynthia	Chief Scientific Officer	A Award deriv	2022-01-06	2022-01-14	79,516	—	$0	79,516	SEC↗
Karunatilake Chulani	Chief Technology Officer	A Award deriv	2022-01-06	2022-01-18	34,258	—	$0	34,258	SEC↗
Lubman Ellen	Chief Business Officer	A Award deriv	2022-01-06	2022-01-18	51,088	—	$0	51,088	SEC↗
HICKLIN DANIEL J	See Remarks	A Award deriv	2022-01-06	2022-01-18	215,888	—	$0	215,888	SEC↗
Trost Timothy W.	Chief Financial Officer	A Award deriv	2022-01-06	2022-01-18	65,960	—	$0	65,960	SEC↗
Leonard Reid	Chief Operating Officer	A Award deriv	2022-01-06	2022-01-18	70,967	—	$0	70,967	SEC↗
Isaacs Randi	Chief Medical Officer	A Award deriv	2022-01-06	2022-01-18	79,516	—	$0	79,516	SEC↗
Leonard Reid	Chief Operating Officer	M Exercise deriv	2021-12-30	2022-01-04	14,102	—	$0	47,034	SEC↗
Leonard Reid	Chief Operating Officer	M Exercise	2021-12-30	2022-01-04	14,102	$1.56	$22.0K	14,102	SEC↗
Leonard Reid	Chief Operating Officer	S Sale	2021-12-15	2021-12-17	2,865	$13.39	$38.4K	122,292	SEC↗
Leonard Reid	Chief Operating Officer	S Sale	2021-12-15	2021-12-17	135	$13.97	$1.9K	122,157	SEC↗
Chatterjee Meeta	Director	A Award deriv	2021-10-28	2021-11-01	23,200	—	$0	23,200	SEC↗
Karunatilake Chulani	Chief Technology Officer	A Award deriv	2021-07-01	2021-07-02	272,000	—	$0	272,000	SEC↗
RA Capital Healthcare Fund LP	Director, 10% Owner	P Buy	2021-06-16	2021-06-16	9,285	$13.37	$124.1K	4,291,881	SEC↗
RA Capital Healthcare Fund LP	Director, 10% Owner	P Buy	2021-06-15	2021-06-16	7,958	$12.95	$103.1K	4,282,596	SEC↗
RA Capital Healthcare Fund LP	Director, 10% Owner	P Buy	2021-06-14	2021-06-16	306,055	$12.75	$3.90M	4,274,638	SEC↗
Sherman Michael A.	Director	A Award deriv	2021-05-27	2021-05-28	23,200	—	$0	23,200	SEC↗
Flynn James E	10% Owner	C Conversion deriv	2021-05-04	2021-05-04	15,195,094	—	$0	0	SEC↗
Sphera Global Healthcare Manag	10% Owner	C Conversion deriv	2021-05-04	2021-05-04	2,713,410	—	$0	0	SEC↗
UPMC	10% Owner	C Conversion deriv	2021-05-04	2021-05-04	2,373,701	—	$0	0	SEC↗
UPMC	10% Owner	C Conversion deriv	2021-05-04	2021-05-04	7,142,857	—	$0	0	SEC↗
Lazarus Alon	Director, 10% Owner	C Conversion deriv	2021-05-04	2021-05-04	3,560,551	—	$0	0	SEC↗
Lazarus Alon	Director, 10% Owner	C Conversion deriv	2021-05-04	2021-05-04	10,714,284	—	$0	0	SEC↗
Longwood Fund III, L.P.	10% Owner	C Conversion deriv	2021-05-04	2021-05-04	9,285,714	—	$0	0	SEC↗
Longwood Fund III, L.P.	10% Owner	C Conversion deriv	2021-05-04	2021-05-04	3,085,811	—	$0	0	SEC↗
Asanuma Sakae	Director, 10% Owner	C Conversion deriv	2021-05-04	2021-05-04	3,797,921	—	$0	0	SEC↗
Asanuma Sakae	Director, 10% Owner	C Conversion deriv	2021-05-04	2021-05-04	11,428,570	—	$0	0	SEC↗
Arkin Moshe	10% Owner	C Conversion deriv	2021-05-04	2021-05-04	10,714,284	—	$0	0	SEC↗
Arkin Moshe	10% Owner	C Conversion deriv	2021-05-04	2021-05-04	3,560,551	—	$0	0	SEC↗
Taiho Ventures LLC	10% Owner	C Conversion deriv	2021-05-04	2021-05-04	3,797,921	—	$0	0	SEC↗
Taiho Ventures LLC	10% Owner	C Conversion deriv	2021-05-04	2021-05-04	11,428,570	—	$0	0	SEC↗
HBM Healthcare Investments (Ca	10% Owner	C Conversion deriv	2021-05-04	2021-05-05	5,426,819	—	$0	0	SEC↗
EVNIN LUKE	Director, 10% Owner	C Conversion deriv	2021-05-04	2021-05-06	23,892,677	—	$0	0	SEC↗
EVNIN LUKE	Director, 10% Owner	C Conversion deriv	2021-05-04	2021-05-06	7,939,970	—	$0	0	SEC↗
MPM Oncology Impact Management	10% Owner	C Conversion deriv	2021-05-04	2021-05-06	38,817,998	—	$0	0	SEC↗
MPM Oncology Impact Management	10% Owner	C Conversion deriv	2021-05-04	2021-05-06	12,899,925	—	$0	0	SEC↗
MPM BioVentures 2014 LLC	10% Owner	C Conversion deriv	2021-05-04	2021-05-06	6,621,546	—	$0	0	SEC↗
MPM BioVentures 2014 LLC	10% Owner	C Conversion deriv	2021-05-04	2021-05-06	19,925,321	—	$0	0	SEC↗
Shah Rajeev M.	Director, 10% Owner	C Conversion deriv	2021-05-04	2021-05-06	2,930,482	—	$0	0	SEC↗
Shah Rajeev M.	Director, 10% Owner	C Conversion deriv	2021-05-04	2021-05-06	16,606,068	—	$0	0	SEC↗
Flynn James E	10% Owner	P Buy	2021-05-04	2021-05-04	800,000	$16.00	$12.80M	2,552,787	SEC↗
Flynn James E	10% Owner	C Conversion	2021-05-04	2021-05-04	1,752,787	—	$0	1,752,787	SEC↗
Sphera Global Healthcare Manag	10% Owner	P Buy	2021-05-04	2021-05-04	475,000	$16.00	$7.60M	787,997	SEC↗
Sphera Global Healthcare Manag	10% Owner	C Conversion	2021-05-04	2021-05-04	312,997	—	$0	312,997	SEC↗
UPMC	10% Owner	C Conversion	2021-05-04	2021-05-04	823,945	—	$0	823,945	SEC↗
UPMC	10% Owner	C Conversion	2021-05-04	2021-05-04	273,811	—	$0	1,097,756	SEC↗
Lazarus Alon	Director, 10% Owner	C Conversion	2021-05-04	2021-05-04	1,235,917	—	$0	1,235,917	SEC↗
Lazarus Alon	Director, 10% Owner	C Conversion	2021-05-04	2021-05-04	410,717	—	$0	1,646,634	SEC↗
Lazarus Alon	Director, 10% Owner	P Buy	2021-05-04	2021-05-04	400,000	$16.00	$6.40M	2,046,634	SEC↗
Longwood Fund III, L.P.	10% Owner	P Buy	2021-05-04	2021-05-04	250,000	$16.00	$4.00M	1,677,082	SEC↗
Longwood Fund III, L.P.	10% Owner	C Conversion	2021-05-04	2021-05-04	1,071,127	—	$0	1,071,127	SEC↗
Longwood Fund III, L.P.	10% Owner	C Conversion	2021-05-04	2021-05-04	355,955	—	$0	1,427,082	SEC↗
Asanuma Sakae	Director, 10% Owner	P Buy	2021-05-04	2021-05-04	312,500	$16.00	$5.00M	2,068,909	SEC↗
Asanuma Sakae	Director, 10% Owner	C Conversion	2021-05-04	2021-05-04	438,098	—	$0	1,756,409	SEC↗
Asanuma Sakae	Director, 10% Owner	C Conversion	2021-05-04	2021-05-04	1,318,311	—	$0	1,318,311	SEC↗
Arkin Moshe	10% Owner	C Conversion	2021-05-04	2021-05-04	1,235,917	—	$0	1,235,917	SEC↗
Arkin Moshe	10% Owner	C Conversion	2021-05-04	2021-05-04	410,717	—	$0	1,646,634	SEC↗
Arkin Moshe	10% Owner	P Buy	2021-05-04	2021-05-04	400,000	$16.00	$6.40M	2,046,634	SEC↗
Taiho Ventures LLC	10% Owner	C Conversion	2021-05-04	2021-05-04	438,098	—	$0	1,756,409	SEC↗
Taiho Ventures LLC	10% Owner	C Conversion	2021-05-04	2021-05-04	1,318,311	—	$0	1,318,311	SEC↗
Taiho Ventures LLC	10% Owner	P Buy	2021-05-04	2021-05-04	312,500	$16.00	$5.00M	2,068,909	SEC↗